ASML is seeing valuation pressure despite stable sales and rising net income, as forward risks from export restrictions remain unresolved. China sales have fallen from nearly half to under 20%, and outlook will depend on changes to US export rules. Updated guidance calls for €43–45B revenue and 54–56% gross margin, supported by EUV/DUV capacity expansion.
ASML’s near-term earnings power is not the issue; the market is pricing a lower durability of those earnings. Once China stops being a dependable end-market, the valuation should behave less like a monopoly compounder and more like a geopolitically capped industrial franchise, which can compress the multiple even if reported sales stay steady for several quarters.
The second-order winner is not necessarily the whole semiconductor equipment complex, but the names with less policy beta and more diversified service/upgrade exposure. AMAT, KLAC, and LRCX can benefit if capital rotates away from the single-name premium in ASML, while Chinese domestic toolmakers and China-dependent fabs face a longer substitution cycle as they are forced into older-node or non-EUV workarounds.
The catalyst path is Washington, not Amsterdam: any tightening around DUV servicing, parts, or end-user licensing would hit backlog visibility within 1-2 quarters, while a benign policy outcome could quickly re-rate the stock because expectations are already cautious. The contrarian point is that the market may be over-anchoring on the China revenue mix change and underestimating how much of ASML’s economics are driven by non-China AI/foundry capex and installed-base economics over 6-18 months. What would falsify the bearish thesis is sustained order intake acceleration outside China and gross margin holding in the mid-50s despite policy noise.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
